ML22164A816

Shine Technologies, LLC Submittal of Annual Financial Report

ML22164A816
Person / Time
Site:	SHINE Medical Technologies
Issue date:	06/13/2022
From:	Jim Costedio SHINE Technologies
To:	Document Control Desk, Office of Nuclear Reactor Regulation
Shared Package
ML22164A815	List: ML22164A816 ML22164A818
References
2022-SMT-0069
Download: ML22164A816 (1)

Text




       

THIS LETTER CONTAINS PROPRIETARY INFORMATION IN ACCORDANCE WITH 10 CFR 2.390 June 13, 2022 2022-SMT-0069 10 CFR 50.71(b)

U.S. Nuclear Regulatory Commission ATTN: Document Control Desk Washington, DC 20555 SHINE Technologies, LLC Submittal of Annual Financial Report SHINE Technologies, LLC (SHINE) hereby submits its annual financial report, including certified financial statements, in accordance with the requirements of 10 CFR 50.71(b).

Enclosure 1 provides the annual financial report of Illuminated Holdings, Inc. (Illuminated).

SHINE is a subsidiary of Illuminated. SHINE requests that the NRC withhold Enclosure 1, in its entirety, from public disclosure under 10 CFR 2.390.

Enclosure 2 provides an affidavit supporting the proprietary treatment of the SHINE proprietary information contained in Enclosure 1, pursuant to 10 CFR 2.390. SHINE requests that the NRC withhold Enclosure 1, in its entirety, from public disclosure under 10 CFR 2.390. Upon removal of Enclosure 1, this letter is uncontrolled.

If you have any questions, please contact Mr. Jeff Bartelme, Director of Licensing, at 608/210-1735.

I declare under the penalty of perjury that the foregoing is true and correct.

Executed on June 13, 2022.

Very truly yours, James Costedio Vice President of Regulatory Affairs and Quality SHINE Technologies, LLC Docket No. 50-608 cc: Project Manager, USNRC SHINE General Counsel Supervisor, Radioactive Materials Program, Wisconsin Division of Public Health (w/o Enclosure 1) 3400 Innovation Ct.

• Janesville, WI 53546

• 877.512.6554

• info@shinemed.com

• www.SHINEtechnologies.com